Patents by Inventor Ming-Sing Si

Ming-Sing Si has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240139378
    Abstract: Provided herein is technology relating to engineered tissues and particularly, but not exclusively, to methods, compositions, and systems for engineering a biosynthetic vascular network.
    Type: Application
    Filed: February 13, 2023
    Publication date: May 2, 2024
    Inventors: Ming-Sing SI, Josue CHERY, Shuyun WANG
  • Patent number: 11577002
    Abstract: Provided herein is technology relating to engineered tissues and particularly, but not exclusively, to methods, compositions, and systems for engineering a biosynthetic vascular network.
    Type: Grant
    Filed: December 5, 2017
    Date of Patent: February 14, 2023
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Ming-Sing Si, Josue Chery, Shuyun Wang
  • Publication number: 20190374682
    Abstract: Provided herein is technology relating to engineered tissues and particularly, but not exclusively, to methods, compositions, and systems for engineering a biosynthetic vascular network.
    Type: Application
    Filed: December 5, 2017
    Publication date: December 12, 2019
    Inventors: Ming-Sing SI, Josue CHERY, Shuyun WANG
  • Publication number: 20080207496
    Abstract: A combination which comprises (a) a staurosporine derivative and (b) an agent effective in preventing, delaying or treating transplant rejection in which the active ingredients (a) and (b) are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier; for simultaneous, separate or sequential use.
    Type: Application
    Filed: April 18, 2008
    Publication date: August 28, 2008
    Inventors: Ming-Sing Si, Dominic C. Borie, Bruce A. Reitz
  • Publication number: 20050159404
    Abstract: A combination which comprises (a) a staurosporine derivative and (b) an agent effective in preventing, delaying or treating transplant rejection in which the active ingredients (a) and (b) are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier; for simultaneous, separate or sequential use.
    Type: Application
    Filed: September 8, 2004
    Publication date: July 21, 2005
    Inventors: Ming-Sing Si, Dominic Borie, Bruce Reitz